Therapeutic indications

Almotriptan is indicated for:

Migraine attacks

Population group: both men and women, only adults (18 years old or older)

Almotriptan is indicated for the acute treatment of the headache phase of migraine attacks with or without aura.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Almotriptan is contraindicated in the following cases:

Ischaemic heart disease, hypertension

at least one of
Ischaemic heart diseases

High blood pressure



Ergotamine, ergotamine derivatives, 5-HT1B/1D agonists

at least one of
Ergot alkaloids

Ergot alkaloids

Ergot alkaloids

Ergot alkaloids

Selective serotonin (5HT1) agonists

Cerebrovascular accident (CVA) or transient ischaemic attack (TIA), peripheral vascular disease

at least one of
CVA - Cerebrovascular accident


Peripheral vascular disease

Severe hepatic disease

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines